About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

European Platform for Regulatory Science Research – Call for expression of interest for academia

European Medicines Agency Logo

Dear participants of the EMA Advancing regulatory science research event,

We are pleased to announce that the call for expression of interest for academia to participate in the new European Platform for Regulatory Science Research is open, with a deadline of 24 January 2025. The submission is encouraged by 24 January 2025, but the call will remain open over the course of 2025

There are two ways to join the initiative

1. as nominated member of the steering group

2. as platform participant

Launching in 2025, the European Platform for Regulatory Science Research, brings together academia and regulators as well as other relevant stakeholders to accelerate impactful, collaborative regulatory science research solutions for global progress. More information about the EMA/HMA European Platform for Regulatory Science Research can be found in the Draft concept paper and on the Advancing Regulatory Science Research EMA webpage.

Please find via this link the form with more information about this call for expression of interest with a form for submission. 

How to join?

For those interested to invest themselves in the Steering group, we would appreciate to receive your expression of interest by completing the form on document page 4 and 5 (form accessible via this link) by 24 January 2025 and submit it to regulatory.science@ema.europa.eu. The selection of Steering group members is expected to be finalised by the end of January and a first kick off meeting of the steering group will be tentatively scheduled in the second half of February 2025.  

For those interested to participate in the Platform participant group, we would appreciate to receive your expression of interest by completing the form on document page 6 (form accessible via this link) and submit it to regulatory.science@ema.europa.eu. The submission is encouraged by 24 January 2025, but the call will remain open over the course of 2025. A first platform participant meeting is expected to take place in March/April 2025.

second call for expression of interest for patients, healthcare professionals, industry, and HTA bodies to participate will open later in 2025.

For any query, please direct it to regulatory.science@ema.europa.eu.

For those who joined the Advancing regulatory science research event on 18 November, we kindly would like to remind you that providing feedback on the event is still possible until 24 January: EUSurvey – Survey

Thank you in advance for your contributions and we look forward to your participation.

Kind regards,

Liese Barbier (EMA), Marjon Pasmooij (MEB), Ralf Herold (EMA)

Regulatory Science and Innovation Task Force
European Medicines Agency